Deals
High-Tech Gründerfonds et al. invest in design2desire
High-Tech Gründerfonds has led a funding round in design furniture maker design2desire.
EQT's Actavis still in the race for for ratiopharm
According to reports, EQT-backed Actavis is still left in the race for generic drugs group ratiopharm being sold by VEM Vermoegensverwaltung GmbH.
Consortium funds Cuculus with EUR 2.6m
Yellow&Blue Investment Management has led a EUR 2.6m round in smart metering company Cuculus GmbH.
NextStage invests EUR 4m in Dallavalle
NextStage has provided Dallavalle, a construction company, with a EUR 4m investment.
EdRIP and UI gestion stage OBO of Segex
Edmond de Rothschild Investment Partners (EdRIP), UI Gestion and Socadif have staged an OBO of the Segex Group, a civil engineering company, alongside the management.
Advent et al lead $1.1bn Skillsoft LBO
A private equity consortium including Berkshire Partners, Advent International and Bain Capital has agreed to acquire Irish e-learning software maker SkillSoft Plc, in an all-cash deal valued at $1.1bn.
CapMan winds down Finnventure funds; exits Turo Tailor
Finnish GP CapMan has sold Turo Tailor AB, a producer of men's suits, to the company's management. The business was the last investment in the Finnventure funds.
KBC to sell private equity wing
As previously reported in unquote, KBC Groupe NV, a Belgian bank, is set to sell its private equity arm by the end of 2010 having received a number of offers for the division.
No go for IPOs as New Look compounds listless week
While talk is still ongoing regarding the flurry of GPs signaling their intention to list portfolio companies, many are already postponing plans as prices fall far below expectations. Francois Rowell reports
Q&A: Hungry for secondaries
The secondaries team of NorgesInvestor is aggressively chasing opportunities in the Nordic region. Rikke Eckhoff asks partner Dylan Wolff how he sees the secondaries market.
Bencis acquires Saval and Knowsley from Imtech
Bencis Capital Partners has acquired extinguishing systems specialists Saval and Knowsley from parent company Imtech.
Beringea further invests £800,000 in Eagle Rock
Beringea has further invested £800,000 in music publishing company Eagle Rock Entertainment in a second round of funding.
Bencis-backed Quaron to be acquired by Univar
Bencis Capital has agreed to sell its chemical manufacturer Quaron Group to trade player Univar.
3i completes exit of Telecity; reaps 5x return
3i has sold its remaining 16.5% stake in listed Telecity Group, a provider of premium network independent data centres, at a price of 345p, realising proceeds of £111m.
Maven backs £5.5m take private of LitComp
Maven Capital Partners has backed the public-to-private acquisition of AIM-listed LitComp Plc, the insurance business, in a £5.48m deal.
Electra Partners backs £270m buyout of esure
Electra Partners, together with limited partner Penta Capital, have backed the buyout of esure in a deal valued at around £270m, acquiring Lloyds Banking Group's 70% stake.
CVC's Evonik to divest minority stake in energy business
Evonik, in which CVC Capital Partners holds a minority stake, is weighing the sale of a minority stake of its energy division.
Denham divests SunRay
Denham Capital Partners have divested SunRay Renewable Energy an solar photovoltaic developer to US-based trade player SunPower, the total consideration for the acquisition is approximately $277m, including $235m in cash and $42m in a letter of credit...
CapMan invests in Hermelinen
CapMan has invested the Swedish private health care centre Hermelinen.
MySQL founder backs MoSync
VC firm Open Ocean Capital, backed by MySQL founder Michael "Monty" Widenius has invested an undisclosed sum in MoSync, a provider of mobile application tools for standardisation.
Hygea et al invest £2.7m in Glide Pharma
Existing investors Hygea VCT and Oxford Technology VCT have further invested in drug company Glide Pharma as part of a £2.7m fourth round of funding, alongside Oxford Capital Partners and private backers.
CRB’s OWL Genomics acquires 70% stake of MD Renal
Cross Road Biotech (CRB) portfolio company OWL Genomics has acquired a 70% stake in sector business MD Renal.
YFM-backed Fishawack acquires Nexus Communications
YFM has injected fresh capital to support portfolio company Fishawack Communications, the medical PR company, in its acquisition of US-based Nexus Communications.